SHANGHAI, July 20, 2026 /PRNewswire/ -- Following the landmark success of CPHI & PMEC China in June 2026, which welcomed an unprecedented gathering of industry professionals and fostered pivotal connections across the pharmaceutical supply chain, attention now shifts to South China. Building on this momentum, CPHI & PMEC Shenzhen 2026 will take place from 16-18 September 2026 at Shenzhen Convention & Exhibition Center (SZCEC), addressing the growing demand for access to South China's key pharmaceutical markets.
As a key gateway to the Guangdong-Hong Kong-Macau Greater Bay Area, Shenzhen is uniquely positioned to drive the future of pharma innovation. The region's health industry GDP is projected to surpass 2 trillion CNY by 2028 and reach 2.5 trillion to 3 trillion CNY by 2030, offering unparalleled opportunities for growth and collaboration. Driven by this immense market potential, CPHI & PMEC Shenzhen 2026 is poised to attract an even more diverse and influential contingent of pharmaceutical buyers, hosting over 800 carefully selected exhibiting companies and more than 15,000 professional visitors from both domestic and international markets.
Addressing this market demand, CPHI & PMEC Shenzhen 2026 showcases a comprehensive spectrum of pharmaceutical products and services, including: pharma ingredients, excipients, biotech, AI tech & contract service, finished dosage, natural supply, beauty & cosmetics supply chain, packaging & drug delivery, pharma machinery, laboratory instruments & equipment, clean technology and more.
To further enhance its sourcing capabilities, the 2026 show floor introduces four strategic new zones designed to accelerate market access, including the Biotech zone, the AI tech & Contract service zone, the Smart manufacturing zone, and the highly dynamic Beauty & Cosmetics supply chain zone.
Alongside the exhibition, over 20 high-level conferences and activities will convene regulatory authorities, academic experts, and industry leaders to provide comprehensive insights into policy developments, technological innovations, and market trends. To facilitate strategic business connections, the event offers the Hosted buyer programme, designed to connect qualified international buyers with local suppliers, enabling efficient sourcing discussions and fostering long-term partnerships.
Leveraging Shenzhen's strategic position as a leading innovation hub, CPHI & PMEC Shenzhen 2026 provides an essential platform for pharmaceutical advancement in South China.
Register now for your complimentary badge:
https://reg.cphi-china.cn/en/user/register
Learn more about the event:
https://www.cphi.com/china/en-gb/home.html
Contact Us: CPHIMarketing@imsinoexpo.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Fostering new opportunities in the Greater Bay Area and Asia's Pharmaceutical Industry
- PROCOMER carried out an investment promotion mission in both Asian markets to position Costa Rica as a strategic platform for regional operations.
SAN JOSÉ, Costa Rica, July 21, 2026 /PRNewswire/ -- As part of its strategy to diversify the sources of foreign direct investment (FDI) flowing into the country, the Trade and Investment Promotion Agency of Costa Rica (PROCOMER) conducted an investment promotion mission to South Korea and Japan aimed at strengthening relationships with companies already operating in Costa Rica while positioning the country as a strategic platform for regional business expansion.
The mission included meetings with multinational companies, investors, and business organizations, as well as the Costa Rica Investment Day Seoul 2026 and Costa Rica Investment Day Tokyo 2026 events, which brought together more than 75 business and institutional representatives from both markets. The visit took place at a time when Asian companies are accelerating the diversification of their supply chains and evaluating new locations to strengthen their international operations. Against this backdrop, Costa Rica continues to reinforce its positioning as a competitive investment destination, supported by key advantages including a highly skilled and growing talent pool, political and economic stability, sustainability, legal certainty, and preferential access to major international markets.
"Asia represents a strategic opportunity to diversify the origins of foreign direct investment in Costa Rica. South Korea and Japan are home to globally recognized companies in manufacturing, technology, logistics, and business services, all of which maintain significant international investment capacity. Strengthening our presence in these markets enables us to broaden our pipeline of potential investors, create new opportunities for the country, and continue positioning Costa Rica as a trusted partner for high value-added investment projects across the region," said Mónica Umaña, FDI Attraction Manager at the Trade and Investment Promotion Agency of Costa Rica (PROCOMER).
The mission—joined by Costa Rica's Ambassador to South Korea, Jorge Valerio, and Costa Rica's Ambassador to Japan, Sussi Jiménez—provided an opportunity for PROCOMER to present Costa Rica's value proposition to South Korean and Japanese companies evaluating expansion opportunities across the Americas. The agency also promoted investment opportunities in sectors including light and advanced manufacturing, packaging, construction materials, plastics, chemicals, logistics, distribution, international trade, retail, digital technologies, corporate services, agribusiness, and medical devices. In addition, meetings were held with companies already established in Costa Rica to explore new opportunities for growth and expansion.
Beyond showcasing Costa Rica's competitive advantages, PROCOMER met with prospective investors and the headquarters of companies already operating in the country to gain insights into their expansion plans, strengthen long-term relationships, identify emerging investment trends, gather market intelligence, and establish new strategic contacts to support Costa Rica's FDI attraction strategy. South Korean company SAE and Japanese medical technology company Terumo, both of which have operations in Costa Rica, also shared their experiences investing in the country with other potential investors.
Fourteen companies from South Korea and Japan currently operate in Costa Rica, reflecting the diversity and sophistication of Asian investment in the country. Among the success stories is SAE, which operates three highly automated cotton yarn manufacturing facilities. Hitachi has established a corporate and technology services operation in Costa Rica that provides regional and global support in areas including information technology, business process services, and shared business services, reinforcing the country's position as a leading knowledge-intensive services hub. Meanwhile, Terumo operates a high-tech medical device manufacturing facility producing equipment for cardiovascular procedures as well as blood and cell technologies. The company has recently expanded its Costa Rican operation by adding engineering and research and development (R&D) capabilities, further strengthening the country's role as a strategic hub for the global medical device industry.
SAN JOSÉ, Costa Rica, July 21, 2026 /PRNewswire/ -- As part of its strategy to diversify the sources of foreign direct investment (FDI) flowing into the country, the Trade and Investment Promotion Agency of Costa Rica (PROCOMER) conducted an investment promotion mission to South Korea and Japan aimed at strengthening relationships with companies already operating in Costa Rica while positioning the country as a strategic platform for regional business expansion.
The mission included meetings with multinational companies, investors, and business organizations, as well as the Costa Rica Investment Day Seoul 2026 and Costa Rica Investment Day Tokyo 2026 events, which brought together more than 75 business and institutional representatives from both markets. The visit took place at a time when Asian companies are accelerating the diversification of their supply chains and evaluating new locations to strengthen their international operations. Against this backdrop, Costa Rica continues to reinforce its positioning as a competitive investment destination, supported by key advantages including a highly skilled and growing talent pool, political and economic stability, sustainability, legal certainty, and preferential access to major international markets.
"Asia represents a strategic opportunity to diversify the origins of foreign direct investment in Costa Rica. South Korea and Japan are home to globally recognized companies in manufacturing, technology, logistics, and business services, all of which maintain significant international investment capacity. Strengthening our presence in these markets enables us to broaden our pipeline of potential investors, create new opportunities for the country, and continue positioning Costa Rica as a trusted partner for high value-added investment projects across the region," said Mónica Umaña, FDI Attraction Manager at the Trade and Investment Promotion Agency of Costa Rica (PROCOMER).
The mission—joined by Costa Rica's Ambassador to South Korea, Jorge Valerio, and Costa Rica's Ambassador to Japan, Sussi Jiménez—provided an opportunity for PROCOMER to present Costa Rica's value proposition to South Korean and Japanese companies evaluating expansion opportunities across the Americas. The agency also promoted investment opportunities in sectors including light and advanced manufacturing, packaging, construction materials, plastics, chemicals, logistics, distribution, international trade, retail, digital technologies, corporate services, agribusiness, and medical devices. In addition, meetings were held with companies already established in Costa Rica to explore new opportunities for growth and expansion.
Beyond showcasing Costa Rica's competitive advantages, PROCOMER met with prospective investors and the headquarters of companies already operating in the country to gain insights into their expansion plans, strengthen long-term relationships, identify emerging investment trends, gather market intelligence, and establish new strategic contacts to support Costa Rica's FDI attraction strategy. South Korean company SAE and Japanese medical technology company Terumo, both of which have operations in Costa Rica, also shared their experiences investing in the country with other potential investors.
Fourteen companies from South Korea and Japan currently operate in Costa Rica, reflecting the diversity and sophistication of Asian investment in the country. Among the success stories is SAE, which operates three highly automated cotton yarn manufacturing facilities. Hitachi has established a corporate and technology services operation in Costa Rica that provides regional and global support in areas including information technology, business process services, and shared business services, reinforcing the country's position as a leading knowledge-intensive services hub. Meanwhile, Terumo operates a high-tech medical device manufacturing facility producing equipment for cardiovascular procedures as well as blood and cell technologies. The company has recently expanded its Costa Rican operation by adding engineering and research and development (R&D) capabilities, further strengthening the country's role as a strategic hub for the global medical device industry.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Costa Rica Strengthens Engagement with South Korean and Japanese Companies to Attract New Investment
